Global Bionic Devices Research Report 2024: Market to Surpass $10.25+ Billion by 2030, Driven by Transformative Impact on Quality of Life in Retaining Mobility and Independence – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Bionic Devices Market, By Product, By Fixation, By Technology, By End User, Country Wise Market Analysis, Key Company Profiles, Trends and Recent Developments – Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering.


The global bionic devices market was valued at US$ 5.76 Billion in 2023, and is projected to reach US$ 10.29 Billion by 2030

The rising incidence of chronic diseases and disabilities, increasing road accidents, growing incidence of hearing loss, and increasing advancements in product technology are some of the significant factors driving the market for bionic devices.

The demand for bionic devices has surged in recent times because of their transformative effect on the quality of existence. According to the WHO, over 430 million people have debilitating hearing loss, and almost 1.5 billion people have some sort of hearing impairment. The use of assistive devices such as cochlear implants has become critical in assisting persons with hearing loss, thereby driving the market growth.

Furthermore, an estimated 1.2 million people are killed in road crashes each year, and as many as 50 million are injured. This drastic increase in road accidents has resulted in broken and lost limbs. The bionic devices provide these people with a second chance at life, as a result, the adoption of bionic devices among healthcare providers and the population of individuals experiencing limb loss has experienced a substantial surge, that is poised to drive the growth of the market.

North America dominated the global bionic devices market in 2023 and is anticipated to lead the market throughout the forecast period. This dominance can be attributed to various factors such as the robust healthcare infrastructure, excessive healthcare spending, presence of key industry players, increasing incidence of hearing loss, technological advancements, and the growing geriatric population among others.

Europe held the second highest share of the global bionic devices market in 2023, driven by factors such as the growing prevalence of amputation due to chronic conditions, increasing geriatric population, rising cases of hearing impairment, and technological advancements. Asia Pacific is likely to witness the fastest growth over the forecast period, owing to increased incidence of disabilities, rising number of road accidents, growing prevalence of chronic diseases, rapidly improving healthcare infrastructure, and increased levels of discretionary spending. South America and Middle East and Africa are competing closely with each other to grab the maximum share of the bionic devices market.

Additionally, the bionic devices market is significantly influenced by the aging population on a global scale. As life expectancy continues to rise, there is a notable increase in age-related conditions and disabilities. Bionic devices play a vital role in offering older adults opportunities to retain their independence, enhance mobility, and improve their overall quality of life.

By Product: Global Bionic Devices Market – Key Takeaways

Based on product, the neural bionics segment dominated the bionic devices market in 2023, and this trend is expected to continue over the forecast period. The increasing adoption of neural bionic devices can be attributed to ongoing innovations in neural interface technologies, brain-machine interfaces, and neurostimulation devices.

The auditory bionics/cochlear implants segment captured second highest share of the global bionic devices market in 2023. According to the WHO, over 430 million people have debilitating hearing loss, and almost 1.5 billion have some sort of hearing impairment. The increasing consciousness and attractiveness of such implants among scientific professionals and sufferers bolsters their function as frontrunners in the bionic devices market.

The orthopedic bionics is the fastest growing segment of the global bionic devices market, led by the growing amputation rates and novel product launches by prominent companies. These bionic devices may include prosthetic limbs, exoskeletons, and other biomechanical aids that mimic natural movements and restore functional abilities, improving the overall quality of life for individuals with orthopedic challenges.

Heart transplant accounted for the least share of the global bionic devices market in 2023.

By Fixation: Global Bionic Devices Market

Based on fixation, the implantable segment dominated the bionic devices market. Implantable bionic devices are surgically implanted into the body to replace or enhance physiological functions and address a wide range of medical conditions. These devices find applications across various medical domains, including neurology, cardiology, orthopedics, and more.

The wearable/externally worn segment captured a significant share of the global bionic devices market in 2023. Wearable bionic devices offer better cost-effectivity than implantable bionics that are priced at the higher end. High affordability helps wearable devices to promote their usage, especially in emerging markets and, thereby generates robust industry growth opportunities.

By Technology: Global Bionic Devices Market

Based on technology, mechanical bionic devices dominated the global market in 2023. Mechanical gadgets offer tangible answers for mobility impairment and rehabilitation, from prosthetic limbs to exoskeletons. Advancements such as lightweight materials, advanced joints, and responsive control structures enhance capability and personal experience.

The electronic bionic devices captured a significant share of the global bionic devices market in 2023. The increasing cases of road accidents and amputees as well as people born without limbs is likely to propel the segment’s growth.

By End User: Global Bionic Devices Market

Based on end-user, the bionic devices market is dominated by hospitals & clinics. The preference for hospital & clinics-based care in the treatment of chronic disorders, coupled with the availability of specialized units such as the orthopedics department, neurology department, and prosthetics department within these institutions, significantly impacts the demand for advanced bionic devices.

It is predicted that the ambulatory surgical centers will capture nearly a quarter share of the total bionic devices market. Ambulatory surgical centers provide cost-effective services and a convenient environment that is less stressful than what many hospitals can offer.

Key Company Profiles

Abbott Laboratories

Abiomed

Boston Scientific Corporation

Baxter International Inc.

Cochlear Ltd.

Edwards Lifesciences Corp

EKSO Bionics Holdings Inc.

MED-EL Medical Electronics

Medtronic PLC

Open Bionics

Ossur hf. (Now Embla Medical hf.)

ReWalk Robotics Ltd.

Scheck & Siress (Acquired by Hanger, Inc.)

Sonova Holding AG

SynCardia Systems, LLC

Demant A/S

By Product – Global Bionic Devices Market and Forecast

Auditory Bionic/Cochlear Implants

Heart Transplant

Orthopedic Bionics

Neural Bionics

By Fixation – Global Bionic Devices Market and Forecast

Implantable

Wearable/Externally Worn

By Technology – Global Bionic Devices Market and Forecast

Electronic

Mechanical

By End User – Global Bionic Devices Market and Forecast

Hospitals & Clinics

Ambulatory Surgical Centers

Healthcare Facilities

By Region – Global Bionic Devices Market and Forecast

North America

United States

Canada

Mexico

Europe

Germany

France

United Kingdom

Italy

Spain

Switzerland

Belgium

Netherlands

Turkey

Asia Pacific

Japan

China

India

South Korea

Thailand

Malaysia

Indonesia

Australia

New Zealand

South America

Brazil

Argentina

Middle East and Africa

Saudi Arabia

United Arab Emirates

South Africa

For more information about this report visit https://www.researchandmarkets.com/r/49jm1r

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.